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Normal huntan melanocytes are often grown in vitvo 
' in the continuous presence of12-0-tetradecanoylphor-
bol-13-acetate (TPA) for growth in tlitvo. The expres-
sion of protein kinase C (PKC) subspecies, which are 
the major cellular receptors for phorbol esters, was 
examined in melanocytes after long-term treatntent 
with TPA to investigate the role ofPKC subspecies in 
, TP A-dependent cell growth. The PKC enzyme activ-
ity detected in quiescent 1nelanocytes was almost 
completely depleted in cells after incubation with 85 
nM TPA for 48 h. Immunoblot analysis indicated 
that, among the PKC subspecies a, {3, D, E, and ~ 
. expressed in quiescent cells, a-, {3-, 8-, and E-PKC 
were significantly down-regulated, whereas ~-PKC 
1 remained at detectable levels in TP A-treated cells. 
TP A did not significantly affect the expression or 
E isin gcr and Marko [ J] first reported in 1982 that norm al human. m.clanocytes requ.ire .thc co.ntinuou s presence of the phorbo l este r, 12-0-tctradecanoylphorbol-13-ace-tate (TPA), for their pro li feration i11 l'itro. It is generally accepted that the major intracellular receptor for TPA 
is protein kinase C (PKC) L2], a mu ltifunctiona l se rine/threonine 
protein kinase that plays crucial rol es in signal transduction [3,4]. 
PKC is activated by increased amounts of membrane d iacylglycer-
ols that resu lt fi·om agonist-induced hydrol ys is of inositol phospho-
lipids. TPA activates PKC direc tly in a manner ana logous to that of 
diacylgl yce rol both in cells and in a ce ll-fi·ee system. In a va riety of 
tissues and cell types, TPA indu ces persistent activation of PKC and 
then e licits depletion ofPKC or "down-regulation" [2]. Molecular 
clonin g and biochemical ana lysis have revealed the existence of 
multiple subspecies ofPKC, and more than ten subspecies ofPKC, 
including a, {31, {311, y, o, E, 'Y). 8, ~. and .\, have been identified in 
mammalian tissues r4J. Some m embers of the PKC fiunily exhibit 
differential enzyma tic properties and distinct pattems of tissue 
expression and intraceUular loca lization, and thus each member of 
the family is suggested to play a discrete ro le in the processing and 
mod ulation of a val"iety of physiol ogic and pathologic responses to 
extem al signals [3 ,4]. 
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subcellular distribution of ~-PKC in melanocytes. 
lntmunoprecipitation assay revealed that the enzyme 
activity of ~-PKC was increased in both the cytosol 
and particulate cell fractions, but the increase was 
much greater in the latter. The activation of ~-PKC 
lasted for 24 to 48 h after the addition of TPA; 
thereafter, ~-PKC activity returned to basal levels. 
DNA synthesis was shown to change concontitantly 
with the activation of ~-PKC in TPA-treated cells. 
These results indicate that TPA induces not only the 
down-regulation of a-, {3-, 8-, and E-PKC, but also 
long-term activation of ~-PKC in Inelanocytes, and 
that activation of ~-PKC parallels the growth of 
normal human ntelanocytes. Key wot'ds: TPA/mitogeu-
esis. J ltwest Der·matol 105:567-571, 1995 
Since the demonstration that normal human mclanocytes require 
the continuous presence of TPA for growth, much attention ha s 
been focused on the mechanism of the proliferation of m elanocytes 
induced by TPA [5,6). The long-term action ofTPA is thought to 
be important for the growth of m elanocytes, as membrane-per-
m eant diacylglyccrols, whjch arc transient activators of PKC, arc 
unable to stimulate the growth of these cells rsJ. Membrane-
permeant diacylglyce ro ls a rc known simpl y to activate PKC, but do 
not induce PKC down-regulation. Thus, it has been postulated that 
TPA-dependent growth of m elanocytcs is a consequence of the 
down-regulation of PKC indu ced by tumor-promoting phorbol 
esters [5] . Overexpression of a -PKC is associated with reduced 
growth and increased expression of differentiation markers in 
melanoma cells [7]. Therefore, PKC ha s been proposed to inhibit 
the proliferation of these cells . The present study was condu cted to 
investigate the long-te rm effects of TPA on each PKC subspecies. 
T PA treatment caused down-regulation of PKC subspecies a, {3, 8. 
and E but did not affect the expression of ~-PKC in melanocytes. 
Furthermore, TPA induced long-term activation of f:-PKC in 
me lanocytes. These resu lts suggest that PKC subspecies such as a, 
{3, 8, and E may be involved in the inhibi tion of the mjtogenic 
response and that TPA-activated ~-PKC might pla y a role in the 
growth regulation of no rmal human melmwcytes . 
MATER.IALS AND METHODS 
Cell Culture Normal human mclanocytcs were isolated fi·om inf.1n ti lc 
foreskins as described [8]. Melanocytcs were maintained in Ham's F-10 
n1 cd iun1 (An1crican IJiorganics, Inc., Ton:n and a, NY) containing I WX~ feta l 
bovine serum (GITICO Laboratories, Grand Island, NY), 200 U/ ml pcni-
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cillin. 100 J.Lg/ml streptom ycin . 85 nM T PA (Sigma C hemical Co .. St. 
Louis. MO). and 0 .1 mM isobutylmeth ylxa nthinc (S igma) (standard growth 
n1cdiun1). 
Preparation of Total PKC Extract and Cytosol and Particulate 
Fractions Melanocytes were cultured in standard growth medium with-
out T I'A for 72 h to render the ce ll s qui escent. Cell s were then treated with 
85 nM TPA for 48 h o r fo r the indi cated time periods. Quiescent and 
TPA-treated melanocytcs (3-5 X 107 ce ll s) were washed with phosphate-
bufl:c red saline and harvestcd by sc raping in phosphate-buffe red sa line. Cell s 
were then suspended in 4 vo lumes of buffer A: 20 mM Tris/1-ICI (pl-1 8 .0) 
conta ining 10 mM cthylcneglyco l-bi s(f3-aminocthyl ether)- N .N.N' ,N'-
tetraacctic acid (ECTA), 2 mM ethylencdiaminetetrnacetic acid (EDTA). 10 
mM 2-mercaptocthanol. 100 J.Lg/ml lcupeptin , 50 J.LM (p-amidinophenyl) 
methancsulfonyl fluoride hydrochlo rid e (p-APMSF). and 0.5%. (v/v) T riton 
X -1 00. Cells were then lysed by sonication using five 5- second bursts by a 
sonifier (Ultrasonic Processor Model VCSO with 2-mm probe; Sonics & 
Materials. Inc., Danbury, CT) and centrifuged at 100,000 X g fo r 60 min. 
T he supernatan t was used as the total PKC extract. For subcellular 
fractionation of melanocytcs, cells were suspended in 4 volumes o f buffer A 
w itho ut Triton X -1 00, lysed by sonication as described above , and centri-
fu ged at 100,000 X g for 60 min. The resulting ·upernatant was used as the 
cytoso l fraction. The pellet was lysed by sonica tion in buffer A and 
centrifuged at 100,000 X g fo r 60 min , and the supernatant was used as the 
particulate fraction . 
Mono-Q Column Chromatography Eq ual amo unts of pro tein (17 m g) 
of the total PKC extracts of quiescent and TPA-trcatcd m elanocytes were 
applied separately to a Mono-Q 1-IR 10/ 1 0 co lumn (I X 10 em ; Phannacia , 
Pi sca taway, NJ) connected to a fa st-protein liquid ch.romatograph y system 
(Pharmacia) and equi librated befo rehand with buffe r ll: 20 mM Tris/ 1-ICI 
(pl-1 8.0) containing 0.5 mM EGTA, 0.5 mM EDTA , 20 mM 2-mercapto-
ethano l, 20 J.Lgl ml le upeptin , 50 J.LM p-APMSF, 10% (v/v) glycerol, and 
0.02°/., (v/v) T riton X-100. Afrer washing the column w ith 10 ml of buffer 
B. we eluted PKC by ap plica tion of a 50-mllinea r concentration g radient of 
NaCl (0-0.5 M) in buffer l3 at a flow rate ofO.S mllmin. Fractions ofl ml 
each were coll ected. PKC activity was assayed by m easuring the incorpo-
rati on of32P fro m [ y- -' 2P]ATP into m yel.in basic protein (MBP) essentially as 
described [9 , 1 OJ. The reaction mixture (50 J.L I) contained 20 mM T1is/H C l 
(pH 7.5). lO mM MgC12 , 10 J.LM [1'-32P]ATP, 200 J.Lg / ml MBP, 16 J.Lgl ml 
phospha tidylsc rine, 1.6 J.Lgl ml diolein, 10 /.LM CaC12 , and 5 1-J.l of enzyme . 
Basal activity was m easured in the presence of 0.5 mM EGTA instead of 
phosphatidylserine , diolein , and C aC12 . After incubation for 15 mi n at 30"C, 
the reaction was terminated by spotting a 40-J.Ll aliquot of the reaction 
mixture onto P81 paper (Whatman , C li fton, NJ) . The paper was washed 
five times for 5 min each by immersion in 75 mM H 3P04 • Radioactivity was 
quantitated by C herenkov counting using a scintill ation liquid spectrom eter. 
lmmunoblot Analysis Immunoblot analysi s was carried out after partial 
purifi cation of PKC by diethylaminoethyl (DEAE)-cellulose co lumn ch.ro-
matography to reduce nonspecific binding . Total PKC extracts and cytosol 
and particulate fractions of quiescent and TPA-treated m elanocytes w ere 
applied separately to a DEAE-cellulose (DE-52; Wh atman) co lumn (0.5 X 
1 em), which was equilibrated beforehand w ith buffer C : 20 mM Tris/ 1-ICI 
(pl-1 8.0) containing 0.5 mM EGTA , 0.5 mM EDTA, and 10 mM 2-mer-
captoethanol. After tbe column was washed w ith bufrer C containing 20 
mM NaCI , PKC was eluted with 0.7 ml of buffer C containing 400 mM 
NaCI. Eq ual amounts o f protein (33 J.Lg/ lane) eluted from the DEAE-
cellulose column were subjected to sodium dodecylsulfatc-polyacrylamide 
ge l e lectrophoresis (SDS-PAGE) using a 7.5% ge l and transferred to an 
lm rnob il on membrane (Millipore Corp. , Bedford , MA) . The membrane 
was incubated ove.-ni [;h t at room temperature with Tris/NaC I bufrer (1 () 
mM T ri s/ HCI, pH 7.5, ;md 150 mM NaC I) conta ining 3'1., gelaLin and 
0.02% NaN3 , and then allowed to react with po lycl onal. antibody specifi c for 
a-, {3-. 5-, E-, and ~-PKC (C KpVS a -a. C KpV1 f3-a. C KpV30-a. CKpVSE-a, 
and CKpVS~-a. respectively ['I 'll) for I h at room temperature. After washing 
with Tris/NaCI buffCr containin g O.OStX• Tween 20, tl1 c membranes were 
incubated for 30 rnin at room tcmperatur<! w ith the biotin ylated anti-rabbit I[;G 
antibody. and subsequently with th<! avidin-bio t1n )da wd horseradish peroxidase 
complex (Vcctastain Eli te; Vector Laboratories, Burlingame, C A). The colo r 
r<!action was developed using diaminobenzidinc tctrah ydrochloridc and 1-120 2 . 
The a-, /3-, 0- , and E-PKC purifi ed from ra t br"i" j9.10."12] and the recombi-
nant ~- l'I<C ovc rexprcsscd in Chinese hamster ovary ccl.ls [1 3 J were used as 
:1 Utl1cntic CllZytnc smnplcs. 
Itnmunoprecipitation of ~-PKC Q ui escent and TPA-treawd mclano-
cytcs were washed three ti mes with icc-cold phosph ate-buffered saline and 
scraped in to bufl'e r D: 50 mM Tris/1-lC I (pl-1 7 .5) , 150 rnM NaCI, 5 mM 
ECTA , 15 mM /3-glycerophosphate, 1 mM Na.l YO.,, I mM dithiothreito l, 
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Figure 1. TPA induces depletion of PKC activity. The total PKC 
extracts of quiescent (A) and TPA-treatcd (B) melanocytes were subj ected 
separately to Mono-Q column chromatography, and PKC activity was 
assayed as described in Materials a11d Methods. Solid circles, in the presence of 
phosphatidylserinc, diolein , and CaCI2 ; ope11 circles, in the presence ofEGTA 
instead of phosphatidylserine, diolein , and C aC12 ; dashed li11e, NaCl concen-
tration. 
20 J.Lg/mlleupeptin , and 50 J.LM p-APMSF. Cells were sonicated using fi ve 
5- second bursts and centrifuged at 100,000 X g for 15 min . The supernatant 
was used as th e cytosol. Pelle ts were lysed in bufl:c r D containing 1% (v/v) 
Triton X -1 00, sonicated using eight 5-sccond bursts, and centrifuged at 
I 00.000 X g for 15 min. T he supernatant was used as the parti cul ate. Equal 
amounts of protein (0 .2 mg for the cytosol and 0.1 m g for the particulate) 
were immunoprccipitated with 4 J.Ll (for the cytoso l) and 2 J.Ll (for the 
parti cul at<!) o f a nti-~-PKC antibody (CKpV S~-a) fo r 16 h at 0 - 4"C. After 
addition of 20 J.Ll (for the C)' toso l) and 10 J.LI (for th e parti culate) of 
protein-A- coupled Scpharose (Phannacia), the mi xture was incubated for 
~·mo the r 1 h with shaking. The resul tin g inmtun c complex was centrifuged 
and washed twice with buffer D containing 0. 5% Triton X-1 00. ;md once 
with buffer E: 20 mM 1-IEPES (pl-1 7.5) containing O.J mM Na3 VO.,. 0.1 
mM di thiothreitol , 50 J.Lglmlleupcptin , and 50 J.LM p-APMSF. T lw immune 
complex was resuspended in 20 J.L I o f buf!e r E and used fo r kinase assay of 
~- I'KC . T h" aaivity of s-I'KC was assayed by addi ng ·1 0 J.L I of the enzyme 
prepara tion dcscrib<!d above to 15 p.l of tlw reaction mi xtu re containing 20 
mM HEPES (pl-1 7.5), 4 mM MgCI2 , 10 I.LM Jy-3 2 P'JATP. 200 J.Lg/ m l MBP. 
and 30 /J.g/ml phosphatidylse rin c. After incubation lo r 7 min at 30°C. the 
reaction was stopped by addition of SDS-PAC E sample buffer, and the 
samples w<!re boiled for 5 min. Tlwse samples were subj <!ct<!d to SDS-PAGE 
usin g a gradient (5 4% to 201.V.~) ge l. and the phosphorylatio n of M 13P was 
visuali zed by autoradiograp hy. Radioacti vity inco rporated into the Mlll' 
band was quantitated by measuring the intensity of pllotostimulatcd lu mi-
ncsccnc<! using a bioimaging anal yzer (13AS 2000; Fuj i Film. T ok)•O, Japan) . 
Thymidine Incorporation Assay Quiescent melanocytcs (5 X 105 cell 
in 1 ml of culture medium per well) W<!re stimulated with 85 nM TPA. For 
, 
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Figure 2. TPA induces difrerential down-regulation of PKC sub-
species. T he tota l PKC extracts of qui escent {ln11e 1) and TPA-treated {ln11e 
2) mclanocytes were app li ed on DEAE-cellulose column , and eluates were 
subjected to imm unoblot analysis using antibodies aga inst each PKC 
subspecies. as described in JHnrerinls all!! Methods. lrnmunoreactions of each 
PKC subspecies were confi rmed by authentic enzyme samples. 
me last 6 h of each incubatio n. the cell s were cul tured with ["'H) th ymidine 
(0 .5 !-LCi per well ). Acid-precipitable material s were co ll ected on a glass 
filter, and radioactivity was qua ntitated with a liquid scintillation spectrom-
eter. 
Protein Detcrn1ination Protein content was dctennincd by th e 1ncthod 
' of Bradford ["14]. 
RESULTS 
TPA-Treated Melanocytes Show Depletion ofl'KC Activity 
To exa mine the long- term effects of TPA on PKC activity, we 
assayed PKC activ ities fi·om quiescent and TPA-treated melano-
cytes after Mono-Q co lumn chromatography. D istinct PKC activity 
was detected in quiescent melanocytes (Fig l A). In contrast, PKC 
activity was markedly reduced in TPA- treated cells, with very low 
activity o bserved in ti:action numbers 29 - 45 (Fig lB). 
PKC Subspecies Are Differentially Down-Regulated in 
TPA-Treated Melanocytes lmmunoblot analysis using anti -
bodies specific for each PKC subspecies was performed to examine 
the depletion of each PKC subspecies (Fig 2). Types a - , {3- , 8-, e-, 
and ~-PKC were expressed in quiescent melanocytes. Comparison 
2 1 
Cytosol 
Particulate 
Figure 3. Subcellular distribution of ~-PKC. T he cytosol ond partic-
ulate fractio ns of quiescent (/n11r '/) and TPA-treatcd (ln11e 2) m clanocytcs 
were app lied on DEAE-ccllulose column , and cluotcs were subjected to 
immunoblot analysis using on antibod y aga inst s-PKC . OS described in 
M nterinls a11d 1\1/cr/wds. 
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F igure 4. T PA indu ces activation of ~-PKC. s-PKC in the cytoso l and 
particulate from quiescent and TPA-trcatcd mclanocytcs was immunoprc-
cipitated and assayed as described in Matl'ria ls a11d Alctht>ds. Phosphoryla tion 
of M.13P was visualized by autoradiography (top) and onalyzcd by a bioimaging 
analyzer (lmrt1!1 11) . PSL, photostimulated luminescence. 
of immuno reactive PKC prote ins in quiescen t and TPA-treatcd 
ce lls revea led a marked decrease in a -, {3-, 8-, and e-PKC levels in 
TPA-treated cell s. Both a - and {3-PKC were undetectable, and 8-
and e-PKC were reso lved only fa in tly in TPA- treated cell s. In con-
trast, ~-PKC was present at essentially the same levels in TPA-
treated cells and in quiescent cells. decreasing sl ightly after TPA 
treatment. T hus, a - , {3- , 8- , and e-PKC proteins, but not ~-PKC , 
are down-regulated in TPA- treated cells. Subsequem analys is of the 
subcellular localization of ~-PKC (Fig 3) revea led ~-PKC in both 
the cytosol and particulate fractions in quiescen t melanocytes, and 
the immunoreactions of ' - PKC in each fraction were not alte red by 
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Figure 5. Time course of ~-PKC activation by TPA treatment. 
Melanocytes were trcqtcd with TPA for the indicated time periods. t-P.KC 
i11 the cytosol (nJ>CII circles) and particulate (solid circles) was immunoprecipi-
tated and assayed as described in Jltln tcrinls allll Mctlwds. Phosphorylation of 
MBP was analyz~d by a bioimaging ana lyzer. Results arc representative of 
three independent experiments. PSL, photostimulatcd luminescence . 
T PA treatment. T hese results indicate that TPA does not induce 
translocation or down-regulation of ~-PKC. 
~-PKC Is Activated in TPA-Treated Melanocytcs T he en-
zyme activity of ~-PKC was assayed afte r immunoprecipitation to 
remove other prote in kinases. lmmunoprecipi tated ~-PKC was 
quantitated by phosphorylation of MBP i.n tl11:: presence of phos-
phatidylserine without Ca + + (Fig 4), beca use ~-PKC is active 
under these conditions [15-18]. TPA treatment induced activation 
of ~-PKC in both the cytosol and particulate. ~-PKC activity 
increased slightly in the cytosol and approximately 2.4-fold in the 
particulate. T ime-course analysis indicated that ~-PKC activity in 
the particulate was highest 24 h afte r TPA treatment among the 
time points examin ed and returned to basa l levels at 72 h, whereas 
~-PKC activity in the cytosol increased slightly during the time 
course (Fig 5). 
~-PKC Activity Correlates with DNA Synthesis in Melano-
cytes To examine the relation be tween ~-PKC activity and DNA 
synthes is of me lanocytes, we performed a thymidine incorporation 
assay (Fig 6) . DNA synthesis was highest 24 h after the addition of 
TPA and decreased to basal levels in a pattern that para lleled the 
change in ~-PKC activity. Thus, ~-PKC activity , especially in the 
particul ate fraction, changes concomi tantly with DNA synthesis of 
melanocytes. 
DISCUSSION 
Normal human m elanocytes are known to express several PKC 
subspecies. T he a-, {3-, and E-PKCs have been detected by 
immunoblot analysis [6], and the presence of a-, {3-, 8-, and ~-PKC 
transcripts has been demonstrated by reverse transcriptase-poly-
merase chain reaction [19]. All of these PKC subspecies were 
detected by immunoblot analysis in this study. After TPA treat-
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Figure 6. Time course of the effect of TPA on DNA synthesis. 
Quiescent melanocytcs were stimulated with T PA for the indicated time 
periods, and incorporation of [3 H]thymidinc into cells was measured as 
described in Mnlc>ials nud Methods. Dat.1 points represent the mean ::':: SO of 
triplicate cultures. 
ment, a - , {3-, 0-, and E-PKC are down-regulated , whereas ~-PKC 
is repo rtedly neither translocated nor down-regulated in response 
to acute or chronic exposure to TPA [17,1 8,20 - 23]. ln the present 
study, we found that a - , {3-, 0-, and E-PKC expression in melano-
cytes is down-regulated as in other cells . In light of the proposal 
that TPA-dependent growth of melanocytes is a consequence of the 
down-regulation of PKC [5] , it seems possible that some PKC 
subspecies, especially a- and {3-PKC, which are deple ted com-
pletely by TPA treatment, may be responsible for inhibition of tl~e 
mitogenic response in m elanocytes. 
Our results also indicate that the expression and distribution of 
~-PKC are not affected by long-term treatment with TPA in 
melanocytes. Because ~-PKC has been suggested to play a crucial 
role in mitogenesis [24,25] and ~-PKC is expressed exclusively in 
m elanocytes growing i11 11itro, a role for ~-PKC in m elanocyte 
proliferation is possible. Previous studies have demonstrated the 
insensitivity of ~-PKC to TPA in a cell-free system [15-1 8]. We 
therefore focused on the effect of TPA on ~-PKC activity in 
m elanocytes. TPA induced long-term activation of ~-PKC in these 
cells, although the mechanism of induction remains unclear. One 
possibility is that the activity of ' -PKC is regulated through 
phosphorylation , analogous to the reported phosphorylation of a-
and 13-PKC on tyrosine residues (26-29] and the control of their 
activity through phosphorylation [26-30]. Some PKC subspecies 
activated by TPA might phosphorylate '-PKC, resulting in the 
modulation of its activity. It is also possible that the activity of 
~-PKC is controlled by some binding proteins to ~-PKC. Several 
proteins such as the receptors for activated C -kinases (31], Bruton 
\)'rosine kinase [32], and RAC protein kinase [33] have been shown 
to bind to PKC. These binding proteins might be phosphorylated 
by TPA-activated PKC, and the phosphorylated binding proteins 
m ay act to modulate ~-PKC activity. Further studies are required to 
elucidate the detailed biochemica l mechanism of ~-PKC activation 
in melanocytes. 
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